GNP Guia Naghi & Partners The Legal 500 – The Clients Guide to Law Firms
-1
archive,paged,category,category-pharma-regulatory,category-159,paged-2,category-paged-2,theme-stockholm,qode-social-login-1.1.3,qode-restaurant-1.1.1,stockholm-core-1.1,woocommerce-no-js,select-theme-ver-5.1.8,ajax_fade,page_not_loaded,side_area_over_content,wpb-js-composer js-comp-ver-6.0.5,vc_responsive

Alina Stoica – Disease awareness campaigns developed by pharmaceutical companies – why should such campaigns be conducted on social media platforms

Disease awareness campaigns are not advertisement to medicines Advertisement to medicines can be performed under strictly regulated conditions. Advertisement to RX (i.e., medicines released based on medical prescription) to the general public is prohibited, while advertisement to OTC (i.e., over-the-counter medicines) may be performed while observing

0

Law no. 56/2021 regulating food supplements

By Tudor Nacev The Law regulating food supplements (i.e. Law no. 56/2021) has been recently published in the Official Gazette. The newly published law replaces the Order no. 1069/2017 and aims at providing for general principles in relation to the commercialization process of food supplements in

0